{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T06:35:52Z","timestamp":1792305352244,"version":"4.4.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11894-025-01019-w","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:23:11Z","timestamp":1760347391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Exploring Recent Advances in Colon-targeted Drug Delivery Systems: from Traditional Methods to Advanced Technologies"],"prefix":"10.1007","volume":"27","author":[{"given":"Nidhi","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Akbar","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. K.","family":"Lanjhiyana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"1019_CR1","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10787-023-01140-0","volume":"31","author":"HS Sardou","year":"2023","unstructured":"Sardou HS, Vosough PR, Abbaspour M, Akhgari A, Sathyapalan T, Sahebkar A. A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease. Inflammopharmacology. 2023;31:1095\u2013105. https:\/\/doi.org\/10.1007\/s10787-023-01140-0.","journal-title":"Inflammopharmacology"},{"key":"1019_CR2","doi-asserted-by":"publisher","unstructured":"Ganguly D, Choudhury A, Majumdar S. Development of satranidazole HCl-Loaded oral nanoparticulate formulation for colon targeting and colon cancer therapy associated with inflammatory bowel disease. Curr Pharm Des. 2025;31. https:\/\/doi.org\/10.2174\/0113816128368738250414070421.","DOI":"10.2174\/0113816128368738250414070421"},{"key":"1019_CR3","doi-asserted-by":"publisher","unstructured":"Sarath Chandran C, Sajayan K, Soman JC, Anjana PK, Swathy KK, Vishnu AS, et al. Advancement in targeted drug delivery systems in managing colonic disorders. Advanced drug delivery systems for colonic disorders. Elsevier; 2024. pp. 207\u201321. https:\/\/doi.org\/10.1016\/B978-0-443-14044-0.00001-6.","DOI":"10.1016\/B978-0-443-14044-0.00001-6"},{"key":"1019_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2174\/0125899775364358250124105814","volume":"17","author":"MA Siddiqui","year":"2025","unstructured":"Siddiqui MA, Agrawal N, Jaiswal M, Gupta S, Lanjhiyana SK. An overview of colon specific drug delivery: approaches and evaluation aspects. Current Drug Research Reviews. 2025;17:412\u201327. https:\/\/doi.org\/10.2174\/0125899775364358250124105814.","journal-title":"Current Drug Research Reviews"},{"issue":"4","key":"1019_CR5","doi-asserted-by":"publisher","DOI":"10.1088\/2516-1091\/abab4c","volume":"2","author":"L Barducci","year":"2020","unstructured":"Barducci L, Norton JC, Sarker S, Mohammed S, Jones R, Valdastri P, et al. Fundamentals of the gut for capsule engineers. Prog Biomed Eng. 2020;2(4):042002. https:\/\/doi.org\/10.1088\/2516-1091\/abab4c.","journal-title":"Prog Biomed Eng"},{"key":"1019_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.724980","author":"S Cai","year":"2021","unstructured":"Cai S, Fan Y, Zhang B, Lin J, Yang X, Liu Y, et al. Appendectomy is associated with alteration of human gut bacterial and fungal communities. Front Microbiol. 2021. https:\/\/doi.org\/10.3389\/fmicb.2021.724980.","journal-title":"Front Microbiol"},{"key":"1019_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/CS20180956","volume":"133","author":"L Vitetta","year":"2019","unstructured":"Vitetta L, Chen J, Clarke S. The vermiform appendix: an immunological organ sustaining a Microbiome inoculum. Clin Sci. 2019;133:1\u20138. https:\/\/doi.org\/10.1042\/CS20180956.","journal-title":"Clin Sci"},{"key":"1019_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01196","author":"S Hua","year":"2019","unstructured":"Hua S. Physiological and pharmaceutical considerations for rectal drug formulations. Front Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2019.01196.","journal-title":"Front Pharmacol"},{"key":"1019_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12040296","volume":"12","author":"L Dou","year":"2020","unstructured":"Dou L, Gavins FKH, Mai Y, Madla CM, Taherali F, Orlu M, et al. Effect of food and an animal\u2019s sex on P-glycoprotein expression and luminal fluids in the gastrointestinal tract of Wistar rats. Pharmaceutics. 2020;12:296. https:\/\/doi.org\/10.3390\/pharmaceutics12040296.","journal-title":"Pharmaceutics"},{"key":"1019_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ijpharm.2008.05.012","volume":"364","author":"EL McConnell","year":"2008","unstructured":"McConnell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm. 2008;364:213\u201326. https:\/\/doi.org\/10.1016\/j.ijpharm.2008.05.012.","journal-title":"Int J Pharm"},{"key":"1019_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejpb.2020.06.011","volume":"153","author":"K Pyper","year":"2020","unstructured":"Pyper K, Brouwers J, Augustijns P, Khadra I, Dunn C, Wilson CG, et al. Multidimensional analysis of human intestinal fluid composition. Eur J Pharm Biopharm. 2020;153:226\u201340. https:\/\/doi.org\/10.1016\/j.ejpb.2020.06.011.","journal-title":"Eur J Pharm Biopharm"},{"key":"1019_CR12","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s11095-009-9927-x","volume":"26","author":"A Diakidou","year":"2009","unstructured":"Diakidou A, Vertzoni M, Goumas K, S\u00f6derlind E, Abrahamsson B, Dressman J, et al. Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults. Pharm Res. 2009;26:2141\u201351. https:\/\/doi.org\/10.1007\/s11095-009-9927-x.","journal-title":"Pharm Res"},{"key":"1019_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/nmo.12243","volume":"26","author":"SE Pritchard","year":"2014","unstructured":"Pritchard SE, Marciani L, Garsed KC, Hoad CL, Thongborisute W, Roberts E, et al. Fasting and postprandial volumes of the undisturbed colon: normal values and changes in diarrhea-predominant irritable bowel syndrome measured using serial. Neurogastroenterology Motil. 2014;26:124\u201330. https:\/\/doi.org\/10.1111\/nmo.12243. <\u2009scp\u2009>\u2009MRI","journal-title":"Neurogastroenterology Motil"},{"key":"1019_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jsps.2014.10.001","volume":"24","author":"M Nidhi, Rashid","year":"2016","unstructured":"Nidhi, Rashid M, Kaur V, Hallan SS, Sharma S, Mishra N. Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review. Saudi Pharm J. 2016;24:458\u201372. https:\/\/doi.org\/10.1016\/j.jsps.2014.10.001.","journal-title":"Saudi Pharm J"},{"key":"1019_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.12.074","volume":"558","author":"M Zeeshan","year":"2019","unstructured":"Zeeshan M, Ali H, Khan S, Khan SA, Weigmann B. Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease. Int J Pharm. 2019;558:201\u201314. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.12.074.","journal-title":"Int J Pharm"},{"key":"1019_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.ijpharm.2019.01.066","volume":"559","author":"MNU Nguyen","year":"2019","unstructured":"Nguyen MNU, Tran PHL, Tran TTD. A single-layer film coating for colon-targeted oral delivery. Int J Pharm. 2019;559:402\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.066.","journal-title":"Int J Pharm"},{"key":"1019_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20280","volume":"9","author":"H Tie","year":"2023","unstructured":"Tie H, Wang Y, Shang Y, Li M, Wei X, Wang Z. Fabrication of pH-dependent solid dispersion for oral colon-targeted delivery of notoginsenoside R1 and its protective effects on ulcerative colitis mice. Heliyon. 2023;9:e20280. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e20280.","journal-title":"Heliyon"},{"key":"1019_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/1061186X.2023.2298849","volume":"32","author":"S Arjun","year":"2024","unstructured":"Arjun S, Kulhari U, Padakanti AP, Sahu BD, Chella N. Colon-targeted delivery of niclosamide from solid dispersion employing a pH-dependent polymer via hotmelt extrusion for the treatment of ulcerative colitis in mice. J Drug Target. 2024;32:186\u201399. https:\/\/doi.org\/10.1080\/1061186X.2023.2298849.","journal-title":"J Drug Target"},{"key":"1019_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2024.100233","volume":"7","author":"F Ferraro","year":"2024","unstructured":"Ferraro F, Sonnleitner LM, Neut C, Mahieux S, Verin J, Siepmann J, et al. Colon targeting in rats, dogs and IBD patients with species-independent film coatings. International Journal of Pharmaceutics: X. 2024;7:100233. https:\/\/doi.org\/10.1016\/j.ijpx.2024.100233.","journal-title":"International Journal of Pharmaceutics: X"},{"key":"1019_CR20","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-025-03088-6","volume":"26","author":"R Patil","year":"2025","unstructured":"Patil R, Bule P, Chella N. Exploration of conventional and FDM-mediated 3D printed tablets fabricated using HME-based filaments for pH-dependent drug delivery. AAPS PharmSciTech. 2025;26:96. https:\/\/doi.org\/10.1208\/s12249-025-03088-6.","journal-title":"AAPS PharmSciTech"},{"key":"1019_CR21","doi-asserted-by":"publisher","unstructured":"Ghosh D, Mittal A, Arora MK. Comparative study between pH, time and colonic bacterial enzyme triggered polymers for colonic delivery of coated ketoprofen multi-particulates. Drug Dev Ind Pharm. 2025;1\u201314. https:\/\/doi.org\/10.1080\/03639045.2025.2525951.","DOI":"10.1080\/03639045.2025.2525951"},{"key":"1019_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.146093","volume":"321","author":"MA Abdelaziz","year":"2025","unstructured":"Abdelaziz MA, Alalawy AI, Sobhi M, Alatawi OM, Alaysuy O. Development and characterization of engineered Gingerol loaded chitosan nanoparticles for targeting colon cancer, bacterial infection, and oxidative stress mitigation. Int J Biol Macromol. 2025;321:146093. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146093.","journal-title":"Int J Biol Macromol"},{"key":"1019_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jconrel.2023.04.047","volume":"358","author":"V Doggwiler","year":"2023","unstructured":"Doggwiler V, Puorger C, Paredes V, Lanz M, Nuss KM, Lipps G, et al. Efficient colonic drug delivery in domestic pigs employing a tablet formulation with dual control concept. J Control Release. 2023;358:420\u201338. https:\/\/doi.org\/10.1016\/j.jconrel.2023.04.047.","journal-title":"J Control Release"},{"key":"1019_CR24","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1016\/j.xphs.2024.05.020","volume":"113","author":"V Doggwiler","year":"2024","unstructured":"Doggwiler V, Lanz M, Lipps G, Imanidis G. Mechanistic investigation of enzyme triggered release from a Xyloglucan matrix tablet for controlled colonic drug delivery. J Pharm Sci. 2024;113:2524\u201341. https:\/\/doi.org\/10.1016\/j.xphs.2024.05.020.","journal-title":"J Pharm Sci"},{"key":"1019_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16040508","volume":"16","author":"S Moutaharrik","year":"2024","unstructured":"Moutaharrik S, Palugan L, Cerea M, Meroni G, Casagni E, Roda G, et al. Colon drug delivery systems based on swellable and microbially degradable high-methoxyl pectin: coating process and in vitro performance. Pharmaceutics. 2024;16:508. https:\/\/doi.org\/10.3390\/pharmaceutics16040508.","journal-title":"Pharmaceutics"},{"key":"1019_CR26","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s13346-023-01439-z","volume":"14","author":"S Moutaharrik","year":"2024","unstructured":"Moutaharrik S, Meroni G, Soggiu A, Foppoli A, Cerea M, Palugan L, et al. Guar gum as a microbially degradable component for an oral colon delivery system based on a combination strategy: formulation and in vitro evaluation. Drug Deliv Transl Res. 2024;14:826\u201338. https:\/\/doi.org\/10.1007\/s13346-023-01439-z.","journal-title":"Drug Deliv Transl Res"},{"key":"1019_CR27","doi-asserted-by":"publisher","unstructured":"Kurl S, Kaur G. Development, optimization, and characterization of microbially triggered Mimosa pudica gum\u2013chitosan polyelectrolyte complex for colon-targeted drug delivery. J Biomater Sci Polym Ed. 2025;1\u201323. https:\/\/doi.org\/10.1080\/09205063.2025.2504711.","DOI":"10.1080\/09205063.2025.2504711"},{"key":"1019_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.addr.2018.06.021","volume":"146","author":"NG Kotla","year":"2019","unstructured":"Kotla NG, Rana S, Sivaraman G, Sunnapu O, Vemula PK, Pandit A, et al. Bioresponsive drug delivery systems in intestinal inflammation: state-of-the-art and future perspectives. Adv Drug Deliv Rev. 2019;146:248\u201366. https:\/\/doi.org\/10.1016\/j.addr.2018.06.021.","journal-title":"Adv Drug Deliv Rev"},{"key":"1019_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/app.47960","author":"AM Morales-Burgos","year":"2019","unstructured":"Morales-Burgos AM, Carvajal\u2010Millan E, Rasc\u00f3n\u2010Chu A, Mart\u00ednez\u2010L\u00f3pez AL, Lizardi\u2010Mendoza J, L\u00f3pez\u2010Franco YL, et al. Tailoring reversible insulin aggregates loaded in electrosprayed arabinoxylan microspheres intended for colon\u2010targeted delivery. J Appl Polym Sci. 2019. https:\/\/doi.org\/10.1002\/app.47960.","journal-title":"J Appl Polym Sci"},{"key":"1019_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.reactfunctpolym.2019.104396","volume":"146","author":"C Miramontes-Corona","year":"2020","unstructured":"Miramontes-Corona C, Escalante A, Delgado E, Corona-Gonz\u00e1lez RI, V\u00e1zquez-Torres H, Toriz G. Hydrophobic agave fructans for sustained drug delivery to the human colon. React Funct Polym. 2020;146:104396. https:\/\/doi.org\/10.1016\/j.reactfunctpolym.2019.104396.","journal-title":"React Funct Polym"},{"issue":"1","key":"1019_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0975-7406.76478","volume":"3","author":"R Shaikh","year":"2011","unstructured":"Shaikh R, Raj Singh T, Garland M, Woolfson Ad, Donnelly R. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3:89. https:\/\/doi.org\/10.4103\/0975-7406.76478.","journal-title":"J Pharm Bioallied Sci"},{"key":"1019_CR32","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1002\/jps.24150","volume":"103","author":"MD Del Curto","year":"2014","unstructured":"Del Curto MD, Palugan L, Foppoli A, Zema L, Gazzaniga A, Maroni A. Erodible time-dependent colon delivery systems with improved efficiency in delaying the onset of drug release. J Pharm Sci. 2014;103:3585\u201393. https:\/\/doi.org\/10.1002\/jps.24150.","journal-title":"J Pharm Sci"},{"key":"1019_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122762","volume":"14","author":"A Gazzaniga","year":"2022","unstructured":"Gazzaniga A, Moutaharrik S, Filippin I, Foppoli A, Palugan L, Maroni A, et al. Time-based formulation strategies for colon drug delivery. Pharmaceutics. 2022;14:2762. https:\/\/doi.org\/10.3390\/pharmaceutics14122762.","journal-title":"Pharmaceutics"},{"key":"1019_CR34","doi-asserted-by":"publisher","unstructured":"Kumar Y, Agrawal N, Jaiswal M. Synthesis of some Curcumin derivatives of Non-Steroidal Anti-Inflammatory (NSAIDs) prodrugs for treatment of inflammatory bowel diseases. Res J Pharm Technol. 2023;2733\u201340. https:\/\/doi.org\/10.52711\/0974-360X.2023.00449.","DOI":"10.52711\/0974-360X.2023.00449"},{"key":"1019_CR35","doi-asserted-by":"publisher","first-page":"122937","DOI":"10.1016\/j.ijpharm.2023.122937","volume":"639","author":"N Mishra","year":"2023","unstructured":"Mishra N, Pal S, Sharma M, Nisha R, Raj Pal R, Singh P, et al. Crosslinked and pegylated pectin Chitosan nanoparticles for delivery of phytic acid to colon. Int J Pharm. 2023;639:122937. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122937.","journal-title":"Int J Pharm"},{"key":"1019_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/10837450.2024.2321250","volume":"29","author":"F Soltani","year":"2024","unstructured":"Soltani F, Kamali H, Akhgari A, Afrasiabi Garekani H, Nokhodchi A, Sadeghi F. Formulation and optimization of a single-layer coat for targeting Budesonide pellets to the descending colon. Pharm Dev Technol. 2024;29:212\u201320. https:\/\/doi.org\/10.1080\/10837450.2024.2321250.","journal-title":"Pharm Dev Technol"},{"key":"1019_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-02020-x","volume":"40","author":"R Deshmukh","year":"2023","unstructured":"Deshmukh R, Prajapati M, Harwansh RK. A review on emerging targeted therapies for the management of metastatic colorectal cancers. Med Oncol. 2023;40:159. https:\/\/doi.org\/10.1007\/s12032-023-02020-x.","journal-title":"Med Oncol"},{"key":"1019_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.gande.2025.01.002","author":"N Agrawal","year":"2025","unstructured":"Agrawal N, Lanjhiyana SK, Jaiswal M, Siddiqui MA, Gupta S. Colorectal cancer spectrum: from subtypes and epidemiology to oncotherapies. Gastroenterol Endoscopy. 2025. https:\/\/doi.org\/10.1016\/j.gande.2025.01.002.","journal-title":"Gastroenterol Endoscopy"},{"key":"1019_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120884","volume":"313","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Ma R, You C, Leng X, Wang D, Deng S, et al. Hyaluronic acid modified oral drug delivery system with mucoadhesiveness and macrophage-targeting for colitis treatment. Carbohydr Polym. 2023;313:120884. https:\/\/doi.org\/10.1016\/j.carbpol.2023.120884.","journal-title":"Carbohydr Polym"},{"key":"1019_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-57965-6","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, Xie Y, Chen Y, Duan J, Bao C, Wang J, et al. A protease-cleavable liposome for co-delivery of anti-PD-L1 and doxorubicin for colon cancer therapy in mice. Nat Commun. 2025;16:2854. https:\/\/doi.org\/10.1038\/s41467-025-57965-6.","journal-title":"Nat Commun"},{"key":"1019_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.carbpol.2018.05.071","volume":"197","author":"P Dramou","year":"2018","unstructured":"Dramou P, Fizir M, Taleb A, Itatahine A, Dahiru NS, Mehdi YA, et al. Folic acid-conjugated Chitosan oligosaccharide-magnetic Halloysite nanotubes as a delivery system for camptothecin. Carbohydr Polym. 2018;197:117\u201327. https:\/\/doi.org\/10.1016\/j.carbpol.2018.05.071.","journal-title":"Carbohydr Polym"},{"key":"1019_CR42","doi-asserted-by":"publisher","first-page":"26666","DOI":"10.1021\/acsnano.4c05773","volume":"18","author":"X Wan","year":"2024","unstructured":"Wan X, Zhang Y, Wan Y, Xiong M, Xie A, Liang Y, et al. A multifunctional biomimetic nanoplatform for dual tumor targeting-assisted multimodal therapy of colon cancer. ACS Nano. 2024;18:26666\u201389. https:\/\/doi.org\/10.1021\/acsnano.4c05773.","journal-title":"ACS Nano"},{"key":"1019_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135487","volume":"279","author":"SS Ahmed","year":"2024","unstructured":"Ahmed SS, Baba MZ, Wahedi U, Koppula J, Reddy MV, Selvaraj D, et al. Oral delivery of solid lipid nanoparticles surface decorated with hyaluronic acid and bovine serum albumin: a novel approach to treat colon cancer through active targeting. Int J Biol Macromol. 2024;279:135487. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135487.","journal-title":"Int J Biol Macromol"},{"key":"1019_CR44","doi-asserted-by":"publisher","first-page":"3185","DOI":"10.1021\/acsabm.5c00002","volume":"8","author":"T Bhattacharyya","year":"2025","unstructured":"Bhattacharyya T, Das P, Ansari A, Mohan AA, Chandra Y, Narayan KP, et al. Glucocorticoid receptor-targeted nanoliposome for STAT3 inhibition-led myeloid-derived suppressor cell modulation and efficient colon cancer treatment. ACS Appl Bio Mater. 2025;8:3185\u2013204. https:\/\/doi.org\/10.1021\/acsabm.5c00002.","journal-title":"ACS Appl Bio Mater"},{"key":"1019_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165272","volume":"12","author":"GK Nandhra","year":"2023","unstructured":"Nandhra GK, Chaichanavichkij P, Birch M, Scott SM. Gastrointestinal transit times in health as determined using ingestible capsule systems: a systematic review. J Clin Med. 2023;12:5272. https:\/\/doi.org\/10.3390\/jcm12165272.","journal-title":"J Clin Med"},{"key":"1019_CR46","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1021\/acs.molpharmaceut.4c00424","volume":"21","author":"K Korzekwa","year":"2024","unstructured":"Korzekwa K, Nagar S, Clark D, Sciascia T, Hawi A. A continuous intestinal absorption model to predict drug enterohepatic recirculation in healthy humans: nalbuphine as a model substrate. Mol Pharm. 2024;21:4510\u201323. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00424.","journal-title":"Mol Pharm"},{"key":"1019_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119379","volume":"583","author":"F Varum","year":"2020","unstructured":"Varum F, Freire AC, Fadda HM, Bravo R, Basit AW. A dual pH and microbiota-triggered coating (Phloral\u2122) for fail-safe colonic drug release. Int J Pharm. 2020;583:119379. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119379.","journal-title":"Int J Pharm"},{"key":"1019_CR48","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1365-2036.2008.03810.x","volume":"28","author":"VC Ibekwe","year":"2008","unstructured":"Ibekwe VC, Khela MK, Evans DF, Basit AW. A new concept in colonic drug targeting: a combined pH-responsive and bacterially\u2010triggered drug delivery technology. Aliment Pharmacol Ther. 2008;28:911\u20136. https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03810.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"1019_CR49","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ijpharm.2017.07.068","volume":"530","author":"CC Dodoo","year":"2017","unstructured":"Dodoo CC, Wang J, Basit AW, Stapleton P, Gaisford S. Targeted delivery of probiotics to enhance Gastrointestinal stability and intestinal colonisation. Int J Pharm. 2017;530:224\u20139. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.07.068.","journal-title":"Int J Pharm"},{"key":"1019_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119372","volume":"583","author":"F Varum","year":"2020","unstructured":"Varum F, Freire AC, Bravo R, Basit AW. OPTICORE\u2122, an innovative and accurate colonic targeting technology. Int J Pharm. 2020;583:119372. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119372.","journal-title":"Int J Pharm"},{"key":"1019_CR51","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/1061186X.2010.504264","volume":"19","author":"NS Barakat","year":"2011","unstructured":"Barakat NS, Al-Suwayeh SA, Taha EI. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma. J Drug Target. 2011;19:365\u201372. https:\/\/doi.org\/10.3109\/1061186X.2010.504264.","journal-title":"J Drug Target"},{"key":"1019_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmt.2024.102341","volume":"39","author":"Y Mei","year":"2024","unstructured":"Mei Y, Hu J, Cao Y, Gao X, Tang L, Wang W. Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside. Appl Mater Today. 2024;39:102341. https:\/\/doi.org\/10.1016\/j.apmt.2024.102341.","journal-title":"Appl Mater Today"},{"key":"1019_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5001\/omj.2010.24","volume":"25","author":"A Philip","year":"2010","unstructured":"Philip A, Philip B. Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J. 2010;25:70\u20138. https:\/\/doi.org\/10.5001\/omj.2010.24.","journal-title":"Oman Med J"},{"issue":"3","key":"1019_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ejpb.2009.07.002","volume":"73","author":"V Malaterre","year":"2009","unstructured":"Malaterre V, Ogorka J, Loggia N, Gurny R. Oral osmotically driven systems: 30 years of development and clinical use. Eur J Pharm Biopharm. 2009;73(3):311\u201323. https:\/\/doi.org\/10.1016\/j.ejpb.2009.07.002.","journal-title":"Eur J Pharm Biopharm"},{"key":"1019_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.addr.2013.10.001","volume":"71","author":"C Lautenschl\u00e4ger","year":"2014","unstructured":"Lautenschl\u00e4ger C, Schmidt C, Fischer D, Stallmach A. Drug delivery strategies in the therapy of inflammatory bowel disease. Adv Drug Deliv Rev. 2014;71:58\u201376. https:\/\/doi.org\/10.1016\/j.addr.2013.10.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"1019_CR56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/10837450802409412","volume":"14","author":"MM Patel","year":"2009","unstructured":"Patel MM, Shah TJ, Amin AF, Shah NN. Design. Development and optimization of a novel time and pH-dependent colon targeted drug delivery system. Pharm Dev Technol. 2009;14:65\u201372. https:\/\/doi.org\/10.1080\/10837450802409412.","journal-title":"Pharm Dev Technol"},{"key":"1019_CR57","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1517\/17425247.2011.574121","volume":"8","author":"N Shah","year":"2011","unstructured":"Shah N, Shah T, Amin A. Polysaccharides: a targeting strategy for colonic drug delivery. Expert Opin Drug Deliv. 2011;8:779\u201396. https:\/\/doi.org\/10.1517\/17425247.2011.574121.","journal-title":"Expert Opin Drug Deliv"},{"key":"1019_CR58","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-019-1603-9","volume":"21","author":"X Nie","year":"2020","unstructured":"Nie X, Wang B, Hu R, Lu W, Chen J, Liu S, et al. Development and evaluation of controlled and simultaneous release of compound Danshen based on a novel colon-specific osmotic pump capsule. AAPS PharmSciTech. 2020;21:38. https:\/\/doi.org\/10.1208\/s12249-019-1603-9.","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"1019_CR59","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4103\/2230-973X.85969","volume":"1","author":"D Patel","year":"2011","unstructured":"Patel D, Patel C, Jani R. Design and evaluation of colon targeted modified pulsincap delivery of 5-fluorouracil according to circadian rhythm. Int J Pharm Investig. 2011;1:172. https:\/\/doi.org\/10.4103\/2230-973X.85969.","journal-title":"Int J Pharm Investig"},{"key":"1019_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2174\/1567201811310030006","volume":"10","author":"PR Yalavarthi","year":"2013","unstructured":"Yalavarthi PR, Vulava J, Vadlamudi HC, Balambhaigari RY, Nair R. Modified pulsincap of Ibuprofen - a novel approach for chronotherapy. Curr Drug Deliv. 2013;10:299\u2013308. https:\/\/doi.org\/10.2174\/1567201811310030006.","journal-title":"Curr Drug Deliv"},{"key":"1019_CR61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4161\/biom.1.1.17717","volume":"1","author":"D Jain","year":"2011","unstructured":"Jain D, Raturi R, Jain V, Bansal P, Singh R. Recent technologies in pulsatile drug delivery systems. Biomatter. 2011;1:57\u201365. https:\/\/doi.org\/10.4161\/biom.1.1.17717.","journal-title":"Biomatter"},{"key":"1019_CR62","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0378-5173(02)00012-1","volume":"236","author":"HNE Stevens","year":"2002","unstructured":"Stevens HNE, Wilson CG, Welling PG, Bakhshaee M, Binns JS, Perkins AC, et al. Evaluation of Pulsincap\u2122 to provide regional delivery of dofetilide to the human GI tract. Int J Pharm. 2002;236:27\u201334. https:\/\/doi.org\/10.1016\/S0378-5173(02)00012-1.","journal-title":"Int J Pharm"},{"key":"1019_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27092981","volume":"27","author":"K Wang","year":"2022","unstructured":"Wang K, Shen R, Meng T, Hu F, Yuan H. Nano-drug delivery systems based on different targeting mechanisms in the targeted therapy of colorectal cancer. Molecules. 2022;27:2981. https:\/\/doi.org\/10.3390\/molecules27092981.","journal-title":"Molecules"},{"key":"1019_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125375","volume":"673","author":"C Gao","year":"2025","unstructured":"Gao C, Yang Z, Song R, Sheng H, Zhu L. Nanotechnology-based drug delivery system for targeted therapy of ulcerative colitis from traditional Chinese medicine: a review. Int J Pharm. 2025;673:125375. https:\/\/doi.org\/10.1016\/j.ijpharm.2025.125375.","journal-title":"Int J Pharm"},{"key":"1019_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12272-020-01219-0","volume":"43","author":"M Naeem","year":"2020","unstructured":"Naeem M, Awan UA, Subhan F, Cao J, Hlaing SP, Lee J, et al. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Arch Pharm Res. 2020;43:153\u201369. https:\/\/doi.org\/10.1007\/s12272-020-01219-0.","journal-title":"Arch Pharm Res"},{"issue":"5","key":"1019_CR66","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2174\/0113892010242028231002075512","volume":"25","author":"R Deshmukh","year":"2024","unstructured":"Deshmukh R, Prajapati M, Harwansh RK. Management of colorectal cancer using nanocarriers-based drug delivery for herbal bioactives: current and emerging approaches. Curr Pharm Biotechnol. 2024;25(5):599\u2013622. https:\/\/doi.org\/10.2174\/0113892010242028231002075512.","journal-title":"Curr Pharm Biotechnol"},{"key":"1019_CR67","doi-asserted-by":"publisher","first-page":"528","DOI":"10.7150\/thno.87739","volume":"14","author":"Z Zhuo","year":"2024","unstructured":"Zhuo Z, Guo K, Luo Y, Yang Q, Wu H, Zeng R, et al. Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles. Theranostics. 2024;14:528\u201346. https:\/\/doi.org\/10.7150\/thno.87739.","journal-title":"Theranostics"},{"key":"1019_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123229","volume":"232","author":"N Ye","year":"2023","unstructured":"Ye N, Zhao P, Ayue S, Qi S, Ye Y, He H, et al. Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment. Int J Biol Macromol. 2023;232:123229. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123229.","journal-title":"Int J Biol Macromol"},{"key":"1019_CR69","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/20415990.2025.2520735","volume":"16","author":"S Taymouri","year":"2025","unstructured":"Taymouri S, Mirseyfifard S, Shafiee F. Characterization of enteric-coated capsules filled with Colchicine loaded Zein nanoparticles for colon delivery. Ther Deliv. 2025;16:777\u201393. https:\/\/doi.org\/10.1080\/20415990.2025.2520735.","journal-title":"Ther Deliv"},{"key":"1019_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.114805","volume":"254","author":"S Noreen","year":"2025","unstructured":"Noreen S, Pervaiz F, Ijaz M, Hanif MF, Shoukat H, Maqbool I, et al. Novel thiol-functionalized hyaluronic acid-based pH-responsive hydrogel: a promising mucoadhesive drug delivery approach toward the treatment of colorectal cancer. Colloids Surf B Biointerfaces. 2025;254:114805. https:\/\/doi.org\/10.1016\/j.colsurfb.2025.114805.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"1019_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103754","volume":"76","author":"P Dutta","year":"2022","unstructured":"Dutta P, Mukherjee K, Saha A, Das A, Badwaik HR, Giri TK. Colonic delivery of surface charge decorated nanocarrier for IBD therapy. J Drug Deliv Sci Technol. 2022;76:103754. https:\/\/doi.org\/10.1016\/j.jddst.2022.103754.","journal-title":"J Drug Deliv Sci Technol"},{"key":"1019_CR72","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ijbiomac.2022.02.080","volume":"205","author":"SZ Mirdamadian","year":"2022","unstructured":"Mirdamadian SZ, Varshosaz J, Minaiyan M, Taheri A. 3D printed tablets containing oxaliplatin loaded alginate nanoparticles for colon cancer targeted delivery. An in vitro\/in vivo study. Int J Biol Macromol. 2022;205:90\u2013109. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.02.080.","journal-title":"Int J Biol Macromol"},{"key":"1019_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123366","volume":"645","author":"M Asadi","year":"2023","unstructured":"Asadi M, Salehi Z, Akrami M, Hosseinpour M, Jockenh\u00f6vel S, Ghazanfari S. 3D printed pH-responsive tablets containing N-acetylglucosamine-loaded Methylcellulose hydrogel for colon drug delivery applications. Int J Pharm. 2023;645:123366. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123366.","journal-title":"Int J Pharm"},{"key":"1019_CR74","doi-asserted-by":"publisher","first-page":"122680","DOI":"10.1016\/j.ijpharm.2023.122680","volume":"635","author":"YH Ou","year":"2023","unstructured":"Ou YH, Goh WJ, Lim SH. Form & formulation approaches for controllable release in 3D printed colonic targeting (CORR3CT) Budesonide tablet. Int J Pharm. 2023;635:122680. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.122680.","journal-title":"Int J Pharm"},{"key":"1019_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2025.103815","volume":"114","author":"J Musel\u00edk","year":"2025","unstructured":"Musel\u00edk J, Komersov\u00e1 A, Elbl J, Svoboda R, Matzick K, Mach\u00e1\u010dkov\u00e1 J, et al. Tailored biopolymer capsules for colon-specific drug delivery: a 3D printing perspective. J Pharm Sci. 2025;114:103815. https:\/\/doi.org\/10.1016\/j.xphs.2025.103815.","journal-title":"J Pharm Sci"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-01019-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-025-01019-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-025-01019-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T23:01:47Z","timestamp":1772578907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-025-01019-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1007\/s11894-025-01019-w","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}